Reportable Segments | Segment Information: Our three reportable segments include Lithium and Advanced Materials, Bromine Specialties and Refining Solutions. Each segment has a dedicated team of sales, research and development, process engineering, manufacturing and sourcing, and business strategy personnel and has full accountability for improving execution through greater asset and market focus, agility and responsiveness. This structure aligns with the markets and customers we serve through each of the segments. The structure also facilitates the continued standardization of business processes across the organization, and is consistent with the manner in which information is presently used internally by the Company’s chief operating decision maker to evaluate performance and make resource allocation decisions. Summarized financial information concerning our reportable segments is shown in the following tables. The “All Other” category comprises operating segments that did not fit into any of our core businesses. During the first quarter of 2016 , we completed the sales of the metal sulfides business and the minerals-based flame retardants and specialty chemicals businesses. For additional information about these businesses, see Note 3, “Divestitures.” Following the sales of these businesses, the “All Other” category includes only the fine chemistry services business. The Corporate category is not considered to be a segment and includes corporate-related items not allocated to the operating segments. Pension and OPEB service cost (which represents the benefits earned by active employees during the period) and amortization of prior service cost or benefit are allocated to the reportable segments, All Other, and Corporate, whereas the remaining components of pension and OPEB benefits cost or credit (“Non-operating pension and OPEB items”) are included in Corporate. Segment data includes intersegment transfers of raw materials at cost and allocations for certain corporate costs. The Company’s chief operating decision maker uses earnings before interest, taxes, depreciation and amortization, as adjusted on a consistent basis for certain non-recurring or unusual items such as acquisition and integration related costs, utilization of inventory markup, gains or losses on sales of businesses, restructuring charges, facility divestiture charges, non-operating pension and OPEB items and other significant non-recurring items (“adjusted EBITDA”), in a balanced manner and on a segment basis to assess the ongoing performance of the Company’s business segments and to allocate resources. In addition, management uses adjusted EBITDA for business planning purposes and as a significant component in the calculation of performance-based compensation for management and other employees. The Company has reported adjusted EBITDA because management believes it provides transparency to investors and enables period-to-period comparability of financial performance. Adjusted EBITDA is a financial measure that is not required by, or presented in accordance with, U.S. GAAP. Adjusted EBITDA should not be considered as an alternative to Net income (loss) attributable to Albemarle Corporation, the most directly comparable financial measure calculated and reported in accordance with U.S. GAAP, or any other financial measure reported in accordance with U.S. GAAP. Three Months Ended Six Months Ended 2017 2016 2017 2016 (In thousands) Net sales: Lithium and Advanced Materials $ 317,859 $ 233,353 $ 602,234 $ 449,526 Bromine Specialties 203,945 206,863 423,136 403,416 Refining Solutions 184,217 178,012 369,629 348,591 All Other 30,704 50,626 63,123 122,715 Corporate 533 473 1,199 2,290 Total net sales $ 737,258 $ 669,327 $ 1,459,321 $ 1,326,538 Adjusted EBITDA: Lithium and Advanced Materials $ 132,549 $ 82,668 $ 252,571 $ 169,142 Bromine Specialties 62,075 66,562 130,563 128,170 Refining Solutions 50,078 61,586 99,657 116,660 All Other 2,444 876 7,600 9,340 Corporate (28,205 ) (21,221 ) (60,074 ) (40,808 ) Total adjusted EBITDA $ 218,941 $ 190,471 $ 430,317 $ 382,504 See below for a reconciliation of adjusted EBITDA, the non-GAAP financial measure, from Net income (loss) attributable to Albemarle Corporation, the most directly comparable financial measure calculated and reported in accordance with U.S. GAAP (in thousands): Lithium and Advanced Materials Bromine Specialties Refining Solutions Reportable Segments Total All Other Corporate Consolidated Total Three months ended June 30, 2017 Net income (loss) attributable to Albemarle Corporation $ 95,350 $ 51,739 $ 40,463 $ 187,552 $ 152 $ (84,371 ) $ 103,333 Depreciation and amortization 25,278 10,336 9,615 45,229 2,292 1,601 49,122 Utilization of inventory markup (a) 11,921 — — 11,921 — — 11,921 Restructuring and other, net (b) — — — — — 4,235 4,235 Acquisition and integration related costs (c) — — — — — 6,479 6,479 Interest and financing expenses — — — — — 14,590 14,590 Income tax expense — — — — — 23,130 23,130 Non-operating pension and OPEB items — — — — — (1,053 ) (1,053 ) Multiemployer plan shortfall contributions (d) — — — — — 4,940 4,940 Other (e) — — — — — 2,244 2,244 Adjusted EBITDA $ 132,549 $ 62,075 $ 50,078 $ 244,702 $ 2,444 $ (28,205 ) $ 218,941 Three months ended June 30, 2016 Net income (loss) attributable to Albemarle Corporation $ 56,880 $ 56,747 $ 52,472 $ 166,099 $ (1,503 ) $ (479,417 ) $ (314,821 ) Depreciation and amortization 25,788 9,815 9,114 44,717 3,353 1,635 49,705 Gain on sales of businesses (f) — — — — (974 ) — (974 ) Acquisition and integration related costs (c) — — — — — 19,030 19,030 Interest and financing expenses — — — — — 15,800 15,800 Income tax expense — — — — — 23,656 23,656 Loss from discontinued operations (net of tax) — — — — — 398,340 398,340 Non-operating pension and OPEB items — — — — — (265 ) (265 ) Adjusted EBITDA $ 82,668 $ 66,562 $ 61,586 $ 210,816 $ 876 $ (21,221 ) $ 190,471 Six months ended June 30, 2017 Net income (loss) attributable to Albemarle Corporation $ 189,456 $ 110,433 $ 80,937 $ 380,826 $ 3,398 $ (229,678 ) $ 154,546 Depreciation and amortization 48,021 20,130 18,720 86,871 4,202 3,119 94,192 Utilization of inventory markup (a) 22,527 — — 22,527 — — 22,527 Restructuring and other (b) — — — — — 17,141 17,141 Gain on acquisition (g) (7,433 ) — — (7,433 ) — — (7,433 ) Acquisition and integration related costs (c) — — — — — 20,760 20,760 Interest and financing expenses (h) — — — — — 83,103 83,103 Income tax expense — — — — — 35,101 35,101 Non-operating pension and OPEB items — — — — — (2,116 ) (2,116 ) Multiemployer plan shortfall contributions (d) — — — — — 4,940 4,940 Other (e) — — — — — 7,556 7,556 Adjusted EBITDA $ 252,571 $ 130,563 $ 99,657 $ 482,791 $ 7,600 $ (60,074 ) $ 430,317 Six months ended June 30, 2016 Net income (loss) attributable to Albemarle Corporation $ 120,207 $ 108,600 $ 98,786 $ 327,593 $ 129,206 $ (543,434 ) $ (86,635 ) Depreciation and amortization 48,935 19,570 17,874 86,379 3,965 2,970 93,314 (Gain) loss on sales of businesses, net (f) — — — — (123,831 ) 1,533 (122,298 ) Acquisition and integration related costs (c) — — — — — 37,588 37,588 Interest and financing expenses — — — — — 30,914 30,914 Income tax expense — — — — — 49,141 49,141 Loss from discontinued operations (net of tax) — — — — — 381,028 381,028 Non-operating pension and OPEB items — — — — — (548 ) (548 ) Adjusted EBITDA $ 169,142 $ 128,170 $ 116,660 $ 413,972 $ 9,340 $ (40,808 ) $ 382,504 (a) In connection with the acquisition of Jiangli New Materials, the Company valued inventory purchased from Jiangli New Materials at fair value, which resulted in a markup of the underlying net book value of the inventory totaling approximately $23.0 million . The inventory markup is being expensed over the estimated remaining selling period. For the three-month and six-month periods ended June 30, 2017, $11.9 million and $22.5 million , respectively, was included in Cost of goods sold related to the utilization of the inventory markup. (b) During 2017, we initiated action to reduce costs in each of our reportable segments at several locations, primarily at our Lithium sites in Germany. Based on the restructuring plans, we have recorded expenses of $4.2 million in Selling, general and administrative expenses for the three-month period ended June 30, 2017 and $2.9 million in Cost of goods sold, $8.4 million in Selling, general and administrative expenses and $5.8 million in Research and development expenses for the six-month period ended June 30, 2017, primarily related to expected severance payments. The unpaid balance is recorded in Accrued expenses at June 30, 2017, with the expectation that the majority of these plans will be completed by the end of 2017. (c) See Note 2, “Acquisitions,” for additional information. (d) Included shortfall contributions for our multiemployer plan financial improvement plan. See Note 13, “Pension Plans and Other Postretirement Benefits,” for additional information. (e) Included amounts for the three-month and six-month periods ended June 30, 2017 recorded in (1) Selling, general and administrative expenses related to a reversal of an accrual recorded as part of purchase accounting from a previous acquisition of $1.0 million ; and (2) Other expenses, net related to final settlement claims associated with the previous disposal of a business of $2.0 million and the revision of tax indemnification expenses of $1.2 million primarily related to a competent authority agreement for a previously disposed business. Also included in Other expenses, net for the six-month period ended June 30, 2017 are $3.2 million of asset retirement obligation charges related to the revision of an estimate at a site formerly owned by Albemarle and a loss of $2.1 million associated with the previous disposal of a business. (f) See Note 3, “Divestitures,” for additional information. (g) Gain recorded in Other expenses, net related to the acquisition of the remaining 50% interest in Salmag. See Note 2, “Acquisitions,” for additional information. (h) Included in Interest and financing expenses is a loss on early extinguishment of debt of $52.8 million . See Note 10, “Long-term Debt,” for additional information. |